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Summary
Vesicular stomatitis virus (VSV) exerts potent antitumor activity, although the molecular mechanisms underlying its oncolytic
properties remain to be fully clarified. Here, we demonstrate that normally resistant murine embryonic fibroblasts are
rendered highly permissive to VSV replication following cellular transformation, a progression that appears to compromise
the antiviral effects of interferon (IFN). Subsequent studies revealed normal dsRNA-dependent protein kinase (PKR) activa-
tion and phosphorylation of eukaryotic initiation factor 2 (eIF2) . Nevertheless, eIF2B-mediated guanine nucleotide ex-
change activity downstream of eIF2 was frequently aberrant in transformed cells, neutralizing eIF2 phosphorylation and
permitting VSV mRNA translation. Thus, defects in translational regulation can cooperate with impaired IFN signaling to
facilitate VSV replication, and may represent a common hallmark of tumorigenesis.
Introduction carried out by the heteropentameric guanine nucleotide ex-
change factor (GEF) eIF2B. eIF2 with a serine 51-phosphory-
lated  subunit (ser51P) competitively inhibits eIF2B-mediatedVSV, the prototypic member of the family Rhabdoviridae, is an
enveloped virus with a negative-stranded RNA genome that recycling of GDP for GTP on eIF2. Since eIF2 is generally found
in excess of eIF2B, and as eIF2 (ser51P).GDP has an increasedencodes five primary gene products. It was recently discovered
that VSV possesses potent oncolytic activity in tissue culture affinity for eIF2B, recycling of eIF2 and consequent rounds of
translation initiation have been found to be inhibited by phos-cells and in vivo. We and others have since shown that VSV
oncolysis proceeds via the activation of multiple caspase- phorylation of only a small fraction of eIF2 (Clemens and Elia,
1997; Hershey, 1991; Kimball, 1999).dependent apoptotic cascades, and is effective against tumors
exhibiting genetic lesions in several known oncogenic and tu- In addition to activating PKR, dsRNAs produced during viral
replication are also potent inducers of Type I IFN synthesismor-suppressor pathways (Balachandran and Barber, 2000;
Balachandran et al., 2001; Fernandez et al., 2002; Stojdl et al., (Barber, 2001; Stark et al., 1998). Type I (/) IFNs are a family
of pleiotropic cytokines with powerful antiviral and immunomod-2000).
Our previous investigations have shown that both PKR and ulatory activity and are produced by most cells in response to
viral infection (Stark et al., 1998). Following their production,IFN act in concert to inhibit VSV replication in normal cells. PKR
is activated by dsRNAs produced during viral replication, and type I IFNs act in an autocrine manner to induce the expression
of several hundred genes that are required to fortify the antiviralacts early following VSV infection to inhibit translation of viral
transcripts (Balachandran et al., 2000). PKR exerts its translation state, as PKR by itself is not sufficient to thwart VSV infection
in the absence of IFN signaling (Balachandran et al., 2000).inhibitory effects by phosphorylating the  subunit of eIF2 on
serine 51 (Clemens and Elia, 1997). eIF2, comprising three sub- Thus, PKR appears to primarily delay VSV mRNA translation
long enough for IFN to be synthesized and establish a completeunits, , , and , functions with methionyl-tRNAi and GTP
to form the 43S preinitiation complex with the 40S ribosomal antiviral state.
Here, we confirm that the antiviral effects of IFN are compro-subunit. Following binding of mRNA and the 60S subunit to
this complex, hydrolysis of eIF2.GTP occurs and eIF2.GDP is mised upon malignant transformation. We further demonstrate
that translation control downstream of PKR activation and eIF2released. To participate in a subsequent round of translation
initiation, eIF2.GDP must be converted to eIF2.GTP, a process phosphorylation is frequently disregulated in many transformed
S I G N I F I C A N C E
We have developed a fibroblast model system to dissect the molecular determinants of susceptibility to VSV, an oncolytic virus. We
demonstrate that the antiviral effects of IFN, essential for inhibiting VSV replication, are commonly compromised in transformed cells,
and may be a general feature of cellular transformation. However, defects in the IFN antiviral response could not fully explain the
oncolytic activity of VSV. Subsequent analysis showed that defective control of mRNA translation initiation may play a role in
permissiveness to VSV, and represent another feature of transformation. Aside from identifying key cellular pathways involved in
facilitating viral oncolysis, our experimental data lay the framework for the intelligent design of future generations of genetically
engineered oncolytic viruses with increased specificity and potency.
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cells, can cooperate with attenuated IFN antiviral activity to depending on the cell line (Balachandran and Barber, 2000;
Stojdl et al., 2000). It is therefore likely that defective IFN antiviralfacilitate VSV oncolysis, and may be a common feature of tu-
morigenesis. activity may be a common feature of transformed cells.
Kinetic analysis of VSV replication in primaryResults
and transformed cells
If defects in IFN action were solely responsible for the suscepti-Transformed PKR/ MEFs are permissive to VSV
We have previously shown that primary (129terSv  Balb/c) bility of transformed MEFs to VSV, then it would be expected
that ablation of IFN signaling in normal fibroblasts would resultPKR/ MEFs are essentially nonpermissive to VSV (Balachan-
dran et al., 2000). In contrast, PKR/ MEFs treated with neu- in these cells becoming susceptible to VSV infection, with kinet-
ics and magnitude of replication comparable to those seen intralizing antiserum to IFN, or MEFs from PKR/ mice, are very
susceptible to VSV replication. Thus, MEFs of the 129terSv  transformed MEFs (as seen in Figure 1). We therefore infected
primary or transformed PKR/ MEFs with VSV in the presenceBalb/c background are resistant to VSV unless either PKR activ-
ity or IFN signaling is ablated (Figures 1A, 1B, and 1E). We used or absence of potent anti-mIFN-/ neutralizing antiserum, to
eliminate autocrine IFN signaling, and measured viral replicationthese MEFs as a model system to study VSV oncolysis, since
pooled populations of malignantly transformed isogenic cells by immunoblotting for viral proteins at various times p.i. How-
ever, while neutralization of IFN did compromise the host cellcould be readily obtained from these parental fibroblasts by
serial passaging. Initially, we passaged primary MEFs following defense of primary MEFs, the kinetics of VSV replication in
these cells were still significantly delayed when compared toa 3T3 protocol and obtained several populations of immortalized
cells that retained contact inhibition. Upon continuous passag- transformed cells (Figures 3A and 3B). To recapitulate this find-
ing in a different setting, we obtained immortalized STAT1/ing, however, such immortalized cells eventually gave rise to
populations of rapidly growing highly refractile cells that dis- MEFs and transformed them by retroviral transduction of acti-
vated Ras (RasG12V). Viral replication in transformed STAT1/played all the hallmarks of transformation, including greatly in-
creased doubling times, lack of contact inhibition, ability to form MEFs was then compared to their primary counterparts. Again
we found that, despite a complete absence of IFN antiviralcolonies in soft agar, and potential to form tumors in nude mice
(data not shown). Importantly, while the parental PKR/ primary signaling in primary STAT1/ cells, VSV replication still pro-
ceeded with slower kinetics in these cells compared to trans-MEFs were resistant to VSV, their transformed counterparts
became remarkably permissive to VSV replication and cytolysis formed STAT1/ cells (Figure 3C). Next, we compared VSV
replication in PKR/ primary and transformed MEFs, and found(Figures 1C–1E). Similar results were obtained when comparing
human fibroblasts transformed with genetically defined onco- no significant VSV replication in primary PKR-deficient fibro-
blasts until 24–36 hr p.i., whereas the transformed cells derivedgenic elements (i.e., H-rasV12) with their normal parental coun-
terparts (Supplemental Figure S1 at http://www.cancercell.org/ from them supported rapid and robust VSV replication within
2–4 hr p.i. (Figure 3D). Similar results were obtained when acgi/content/full/5/1/51/DC1 and Hahn et al., 1999).
panel of primary and transformed human cell types were com-
pared (Figure 3E). Thus, while defective IFN action indeed con-Defective IFN-mediated antiviral activity
in transformed cells tributes to VSV oncolysis, other factor(s) cooperate to facilitate
robust VSV replication in transformed cells.To examine the IFN system in these cells, we treated primary
and transformed MEFs with synthetic dsRNA (poly [I:C]), or
infected them with VSV, and measured the production of IFN PKR activity and eIF2 phosphorylation
in transformed MEFsover a period of 24 hr by standard inhibition of CPE assay. Both
primary and transformed MEFs produced comparable amounts We sought to examine whether aberrancies in PKR signaling
occurred in transformed MEFs predisposed to VSV oncolysis.of IFN in response to poly (I:C) and after VSV infection (Figures
2A and 2B). In this light, enhanced Ras signaling via activation of the ERK
pathway in transformed cells has been shown to facilitate viralTo examine whether IFN-triggered signal transduction was
impaired in the transformed MEFs, reporter assays using con- oncolysis by abrogating PKR activity (Farassati et al., 2001;
Strong et al., 1998). To examine whether Ras and ERK signalingstructs expressing firefly luciferase under the control of either
a type I IFN stimulated response element (ISRE) or the type II play a role in cellular susceptibility to VSV, a panel of malignantly
transformed human and rodent cell lines were treated with phar-IFN-responsive  activated sequence (GAS) were performed
next. Whereas primary MEFs responded to both mIFN-/ and macological inhibitors of Ras and ERK signaling. No significant
decrease in VSV production was observed when these signalingmIFN-, transformed MEFs were relatively unresponsive to both
(Figures 2C and 2D). A lack of robust IFN-induced gene regula- cascades were inhibited (Supplemental Figure S3 at http://
www.cancercell.org/cgi/content/full/5/1/51/DC1).tion in transformed MEFs was confirmed by immunoblotting for
mIFN-/ and mIFN--inducible gene products STAT-1 and We next directly examined PKR activity and report no sig-
nificant differences between primary and transformed cells inIRF-1 (Figure 2F). Accordingly, while the IFNs were very effective
in inhibiting VSV production from primary cells, these cytokines activation of PKR by either synthetic dsRNA (poly [I:C]) or VSV
(Figure 4A). eIF2 phosphorylation on serine 51 in response towere capable of only partial protection of the majority of trans-
formed cells (Figure 2G). In general, we and others have found both poly (I:C) and VSV was also indistinguishable between
cells resistant and susceptible to VSV (Figure 4A). Thus, thethat IFN pretreatment reduces viral yield from numerous primary
cells to virtually undetectable levels, whereas the same dose of permissiveness of transformed MEFs to VSV does not appear
to require either enhanced Ras and ERK signaling, or defectiveIFN on transformed cells still results in between 1  103–1 
108 plaque forming units (pfu)/ml progeny VSV virion production, PKR activity and consequent eIF2 phosphorylation. Given
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Figure 1. Primary MEFs are protected from VSV by PKR and autocrine IFN, but become susceptible upon transformation
A: Primary MEFs were infected with VSV (m.o.i.  1) in the absence or presence of neutralizing anti-mIFN-/ antiserum for 36 hr and photographed at
200 magnification.
B: Lysates prepared from cells treated as in A were analyzed for VSV replication by immunoblotting.
C: Transformed MEFs were infected with VSV (m.o.i.  1) in the absence or presence of neutralizing anti-mIFN-/ antiserum for 36 hr and photographed
at 200 magnification.
D: Lysates prepared from cells treated as in C were analyzed for VSV replication by immunoblotting. Molecular masses (in kilodaltons [kDa]) are shown to
the left of immunoblot exposures. Identities of individual VSV proteins are shown to the right.
E: Viral progeny yield from cells infected with VSV (m.o.i.  10) in the absence or presence of anti-mIFN-/ neutralizing antiserum was determined 48 hr
p.i. Numbers represent mean PFU/ml virus of duplicate samples from two independent experiments.
these data, it was therefore plausible that elements downstream vation and malfolded proteins in the ER activate two of these
kinases, general control nonderepressible (GCN)2 and PKR-of PKR/eIF2 signaling might be defective in these cells.
like ER resident kinase (PERK), respectively (Hinnebusch, 1994;
Ron, 2002). To determine whether amino acid starvation andDefective translation control downstream of eIF2
phosphorylation in transformed MEFs ER stress resulted in eIF2 phosphorylation by their cognate
kinases, primary and transformed MEFs were treated with theThe inhibition of translation by phosphorylated eIF2 is a major
stress-responsive checkpoint employed by at least three ki- PERK activator tunicamycin or deprived of amino acids and
assayed for eIF2 phosphorylation by immunoblotting. How-nases, in addition to PKR (Hinnebusch, 1994). Amino acid depri-
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Figure 2. IFN signaling, but not production, is defective in transformed MEFs
A: Primary (black bars) or transformed PKR/ MEFs (gray bars) were transfected with poly (I:C) (2 g/ml) and IFN production was determined at the
indicated times.
B: Primary (black bars) or transformed PKR/ MEFs (gray bars) were infected with VSV (m.o.i.  50) and IFN production was determined as in A. Error bars
(in this and other experiments) represent standard error around the mean of triplicate samples from a representative experiment.
C: Primary PKR/ cells were transfected with expression vectors encoding either ISRE-Luc and GAS-Luc, treated with IFN-/ or IFN- respectively, and
luciferase activity measured 18 hr posttreatment.
D: Transformed PKR/ MEFs were treated as in C.
E: A plasmid encoding GFP was transfected into both primary (i and ii) and transformed (ii and iv) MEFs to show comparable transfection efficiencies of
these cells.
F: MEFs were treated with either mIFN-/ or mIFN- for 24 hr, after which lysates were examined for STAT1 and IRF-1 protein levels.
G: Transformed (solid lines) and primary (dashed lines) cell types were treated with the indicated amounts of either mIFN-/ or human IFN- (Hela, 293T,
SAECs [small airway epithelial cells], HMVECs [human microvascular endothelial cells]) after which they were infected with VSV (m.o.i.  10). 24 hr p.i.,
supernatants were collected and viral titers determined.
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Figure 3. Kinetic analysis of VSV replication in pri-
mary and transformed MEFs
A: PKR/ MEFs were infected with VSV (m.o.i. 
10). At the indicated times p.i., cells were lysed
and VSV replication analyzed by immunoblot-
ting.
B: PKR/ MEFs were infected with VSV in the
presence of neutralizing anti-IFN antiserum and
analyzed as above for kinetics of VSV replication.
C: STAT1/ MEFs were infected with VSV, and at
the indicated times p.i., cells were lysed and VSV
replication analyzed by immunoblotting.
D: PKR/ cells were also analyzed as above for
VSV replication by immunoblotting.
E: Three primary (HMVECs, SAECs, and mammary
epithelial cells [MECs]) and three transformed
(HeLa, MCF-7 and 293T) human cell types were
infected with VSV and examined as above for
VSV replication.
ever, neither PERK- nor GCN2-mediated phosphorylation of of transformed MEFs with any of the eIF2 kinase activators
(Figure 4C). To confirm this finding, we measured protein synthe-eIF2 was found to be significantly impaired in transformed
cells (Figure 4B), indicating that stress-responsive eIF2 phos- sis rates by radiolabeled amino acid incorporation and obtained
similar results, suggesting that translational control at the eIF2phorylation per se does not appear defective in transformed
MEFs susceptible to VSV. checkpoint may be defective in transformed MEFs (Figure 4D).
We surmised that this might be a result of aberrant eIF2B-Next, we tested whether stress-specific phosphorylation of
eIF2 in primary and transformed MEFs resulted in the inhibition mediated guanine nucleotide exchange on eIF2, since this is
the primary reaction that is subject to control by eIF2 phos-of translation in these cells. A reporter plasmid encoding firefly
luciferase under the control of a cytomegalovirus immediate phorylation. If eIF2B were to somehow maintain elevated rates
of guanine nucleotide exchange in transformed MEFs despiteearly gene (CMV) promoter was therefore transfected into pri-
mary and transformed MEFs, prior to treatment with either poly robust eIF2 phosphorylation by stress-specific kinases, it
would remain possible that these cells could sustain normal(I:C), tunicamycin, or deprivation of amino acids. Changes in
luciferase activity, reflective of the levels of luciferase protein, rates of mRNA translation despite cellular stress. To test this
hypothesis, we treated primary and transformed MEFs with vari-were used as an indicator of protein synthesis rates. After treat-
ment with the eIF2 kinase activators, luciferase activity ous eIF2 kinase activators and compared the rates at which
guanine nucleotide dissociation from eIF2 occurred. Indeed, wedropped to almost undetectable levels in primary MEFs. In con-
trast, despite identical kinetics and magnitude of eIF2 phos- discovered that transformed MEFs have a greatly increased
ability over primary MEFs to displace bound GDP from eIF2phorylation in primary and transformed cells (Figure 4B), virtually
no decrease in luciferase activity was seen following treatment (compare Figure 4E to 4F). Importantly, none of the eIF2 kinase
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Figure 4. Defective translational control and disregulated eIF2B guanine nucleotide exchange activity downstream of PKR activation and eIF2phosphoryla-
tion in transformed MEFs.
A: MEFs were either mock infected or infected with high m.o.i.s (200) of VSV and examined for PKR and eIF2 phosphorylation by in vivo kinase assay and
immunoblotting using a eIF2 phosphoserine 51-specific antibody, respectively.
B: MEFs were treated with dsRNA (poly [I:C]) or tunicamycin, or deprived of amino acids for 3 hr, and examined for eIF2 phosphorylation by immunoblotting.
C: MEFs were transfected with a luciferase reporter construct, and treated with poly (I:C) or tunicamycin, or deprived of amino acids for 18 hr, after which
luciferase activity was determined.
D: Cells treated as in B, except that only glutamine deprivation was used to activate GCN2, were pulsed for 30 min with [35S]-methionine three hours
posttreatment. Lysates from these cells were subjected to SDS-PAGE/autoradiography (top panel). The autoradiograph was densitometrically scanned,
and the percent change in protein synthesis rates presented quantitatively (bottom panel).
56 CANCER CELL : JANUARY 2004
A R T I C L E
activators used caused eIF2 nucleotide exchange rates in trans- combinant VSV expressing GFP (VSV-GFP). Despite the fact
that immortalized NIH3T3 cells were already moderately permis-formed cells to reduce to even the basal rates seen in primary
MEFs cells (Figures 4E and 4F). Similarly, we found that human sive to VSV, we noticed that infected NIH3T3-eIF2B	 cells exhib-
ited significantly greater CPE and GFP-fluorescence than con-fibroblasts transformed with defined oncogenic elements dis-
played greater basal and post-eIF2 kinase-activated eIF2B trol cells (Figure 5E). In contrast, infected NIH3T3-eIF2B	
C
cells manifested somewhat reduced CPE, and significantly de-GEF rates compared to their parental immortalized cells, despite
normal eIF2phosphorylation (Supplemental Figure S2 at http:// creased GFP fluorescence. In agreement with this, NIH3T3 cells
overexpressing eIF2B	 produced approximately 8-fold more vi-www.cancercell.org/cgi/content/full/5/1/51/DC1).
rus, while cells expressing the 	
C mutant reproducibly pro-
duced about 4- to 5-fold lower titers of progeny VSV than controleIF2B can modulate translation and serve
as a determinant of susceptibility to VSV cells 16 hr p.i. at an m.o.i. of 1 (Figure 5F).
Since the eIF2B is present in rate-limiting amounts in most cells
sensitive to eIF2 phosphorylation, an alteration in the levels Elevated levels of eIF2B are required for increased
permissiveness of transformed MEFs and HeLaand/or activity of this complex could putatively override the
translational block imposed by phosphorylation of eIF2 (Kim- cells to VSV replication
We next employed RNA interference (RNAi) technology to exam-ball, 1999). We therefore sought to examine the levels of the
five subunits of eIF2B by immunoblotting. While the levels of ine whether the elevated levels of eIF2B	 found in transformed
MEFs were required for their increased permissiveness to VSV.four of these subunits were approximately equivalent among
pools of primary and transformed MEFs examined, there was After three days of treatment with short interfering dsRNA du-
plexes (siRNA) directed toward eIF2B	 mRNA, we were able toa dramatic (10-fold) increase in the levels of 	 subunit in all
transformed MEF populations examined, compared to their ge- detect an75% specific decrease in the levels of eIF2B	protein
(Figure 6A). We observed that cells transfected with siRNA tonotype-matched primary cell counterparts (Figure 5A).
As eIF2B	 is the catalytic subunit of eIF2B and has been eIF2B	, but not control cells, were almost completely protected
against VSV-GFP-induced cytolysis 16 hr p.i., and producedshown to possess eIF2 guanine nucleotide exchange activity
(with GDP exchange rates 5%–10% that of the holo-complex approximately 10-fold less virus than control cells (Figures 6B–
6D). To verify this finding, we used HeLa cells in which an siRNA[Fabian et al., 1997; Pavitt et al., 1998; Williams et al., 2001]),
we hypothesized that an increase in the levels of this subunit specific for human eaIF2	 resulted in a reduction of endogenous
pools of eIF2B	 protein to almost undetectable levels (Figurecould enhance translation rates, and possibly neutralize the
consequences of eIF2 phosphorylation by increasing the rate 6E). Progressively greater numbers (20%–30%) of HeLa cells
treated in this fashion underwent apoptotic cell death 4–5 daysof nucleotide exchange on eIF2 (Fabian et al., 1997). To study
the effects of this subunit on translation, we subcloned the full- posttransfection, and most were dead by seven days post-
transfection. (Figure 6F, data not shown). Remarkably, whilelength rat eIF2B	 cDNA into a mammalian expression vector
(Flowers et al., 1996). A variant of this subunit (called eIF2B	
C) HeLa cells treated with the transfection reagent or control siRNA
alone manifested extensive CPE and widespread GFP expres-was generated by deleting its carboxy-terminal 188 amino acids,
shown to be important for enzymatic activity and binding to sion upon infection with VSV-GFP, those treated with siRNA
to eIF2B	 exhibited virtually no evidence of virus replication-eIF2 (Gomez et al., 2002; Figure 5B). In cotransfection experi-
ments using these constructs in combination with an expression induced CPE, even 36 hr posttransfection (Figures 6G and 6F).
eIF2B	 siRNA-treated cells also showed an100-fold decreasevector encoding firefly luciferase, we determined that eIF2B	
was able to moderately stimulate translation (2-fold), while the in viral yield, compared to controls (Figure 6H).
eIF2B	
C mutant suppressed translation by50% (Figure 5C).
These results, taken together with a previous report showing Replicative abilities of recombinant VSV
expressing eIF2B or eIF2Cthat overexpression of Drosophila eIF2B	 in human 293T cells
increases GEF activity on eIF2, would suggest that this subunit, To further investigate the effects of eIF2B	 overexpression on
VSV replication, we generated novel recombinant VSV express-by itself, can affect translation in mammalian cells (Figure 5C;
Williams et al., 2001). ing either full-length rat eIF2B	, or the eIF2B	
C variant (VSV-	
and VSV-	
C, respectively) using described methods (FigureFull-length eIF2B	, as well as eIF2B	
C, was then retrovirally
transduced into NIH3T3 cells to generate cells stably expressing 7A; Lawson, 1995; Fernandez, 2002). Viruses produced in this
fashion were plaque-purified, propagated on transformed BHKthese polypeptides. Immunoblot analysis revealed that cells ob-
tained after retroviral transduction of eIF2B	 or eIF2B	
C had cells, and examined for expression of both recombinant and
viral proteins by immunoblotting (Figure 7B). One-step growthsimilar levels of PKR, eIF2, and the other eIF2B subunits, com-
pared to cells transduced by control retrovirus, while levels of curve analysis revealed that VSV-	 replicated to higher titers (2
log) four hours p.i., compared to VSV-GFP, but then exhibitedectopically overexpressed eIF2B	 were similar to those seen in
transformed MEFs (Figure 5D). These cells were next examined kinetics of replication virtually indistinguishable from VSV-GFP
at later time points. VSV-	
C, in contrast, grew with somewhatfor susceptibility to VSV replication following infection with re-
E: Primary MEFs were treated with poly (I:C) tunicamycin or were grown in medium devoid of glutamine (aa), and eIF2B guanine nucleotide exchange
activity in these cells was determined 3 hr post treatment.
F: Transformed MEFs were treated and processed as in E. The amount of [3H]GDP bound to eIF2 at the start of the reaction (time  0 min) was arbitrarily
set to 100%. Data shown are from one of three experiments with similar results.
CANCER CELL : JANUARY 2004 57
A R T I C L E
Figure 5. eIF2B	 is overexpressed in transformed MEFs and serves as a determinant of permissiveness to VSV
A: Lysates from pools of primary or transformed PKR/, PKR/, or C57Bl/6 fibroblasts were examined by immunoblotting for all eIF2B subunit levels. Numbers
above lanes indicate independently derived pooled cell populations.
B: Schematic of eIF2B	. The 716 amino acid rat eIF2B	 polypeptide has putative catalytic subdomains toward the carboxy end (light gray shading) and
eIF2B-contact regions toward the amino terminus (dark gray shading). Two regions with a high concentration of aromatic and acidic residues, shown to
be critical for eIF2 binding and found in the extreme carboxy terminus of the polypeptide, are also shown ([Asano et al., 1999], black shading). eIF2B	
C,
lacking 188 C-terminal amino acids of the full-length protein, is also depicted. Expression was confirmed by immunoblotting (bottom panels).
C: These constructs were cotransfected with a luciferase reporter construct into the indicated cell types and luciferase activity was measured 18 hr later.
D: NIH3T3 cells expressing empty vector only (NIH3T3-Neo), eIF2B	 (NIH3T3-eIF2B	), or eIF2B	
C (NIH3T3-eIF2B	
C) were created, and expression of all eIF2B
subunits, PKR, and eIF2 were examined by immunoblotting.
E: Populations of these cells were infected with VSV-GFP (m.o.i.  1), and photomicrographs (magnification 200) taken 16 hr p.i.
F: Pools of control, eIF2B	, or eIF2B	
C-expressing NIH3T3 cell populations were infected with VSV-GFP and viral progeny yield determined 16 hr p.i.
slower kinetics than VSV-GFP at later time points, and about serum to Type I IFN. This time, greater differences were ob-
served in the replicative abilities of these viruses in primary4-fold less 	
C-expressing virus was recovered from the culture
supernatant 10 hr p.i. (Figure 7C). PKR/ MEFs. Infection with VSV-	 yielded 10- to 15-fold more
virus than infection with VSV-GFP, while VSV-	
C replicatedNext, we examined whether viruses expressing eIF2B	 or
poorly in normal cells, producing 2- to 3-fold fewer progenyeIF2B	
C were altered in their ability to replicate in normal cells.
virions than control VSV-GFP (Figure 7Dii).Indeed, we found that VSV-	 yielded about 5- to 6-fold more
virus, compared to control VSV-GFP, from primary PKR/
MEFs. In contrast, we were unable to detect any progeny virus Impaired control of translation downstream of eIF2
yield from VSV-	
C-infected primary MEFs (Figure 7Di). Never- phosphorylation in tumorigenic human cells
theless, overall viral yields were low, which we attributed to the Since VSV can replicate in the majority of transformed human
antiviral effects of autocrine IFN. We therefore performed the cell lines, it was plausible that translational control at the eIF2
checkpoint might be defective in such cells. We therefore exam-experiment described above in the presence of neutralizing anti-
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ined the ability of eIF2 kinase activators to inhibit ongoing involved markedly elevated rates of eIF2B-catalyzed dissocia-
tion of GDP from eIF2 in transformed MEFs.translation in a panel of normal and transformed human cell
types. While poly (I:C) or tunicamycin were both able to effec- A number of viruses have been shown to possess oncolytic
activity, and although the mechanisms underlying their oncoly-tively inhibit translation in all normal cells, these agents were
much less capable of decreasing translation rates in any of the sis remain unclear, a role for Ras-dependent signaling has been
shown to dictate the oncolytic abilities of influenza virus, reovi-four transformed cell lines tested at the doses used (Figures
8A and 8B, top panels). Thus, whereas transformed cells are rus, and herpes simplex virus (HSV)-1 (Bergmann et al., 2001;
Farassati et al., 2001; Strong et al., 1998). In our analyses,capable of inhibiting translation following these stresses, they
clearly do so to a lesser degree than do primary cells. Immu- however, we were unable to implicate the Ras pathway in dictat-
ing permissiveness to VSV, indicating that this virus may exploitnoblotting for phosphorylated and total eIF2 revealed that
phosphorylation of eIF2 is not detectably compromised in any Ras-independent defects in host cell defense.
Although activation of PKR and consequent eIF2 phos-of these cells, and, indeed, in most other transformed human
cell lines tested (Figures 8A and 8B, bottom panels, data not phorylation occurred in transformed cells with kinetics and mag-
nitude indistinguishable from normal cells, we report that theshown). We next examined the ability of lysates from various
normal and tumorigenic human cell types to catalyze the dis- accompanying decreases in rates of mRNA translation seen in
primary cells are not mimicked by their transformed counter-placement of [3H]GDP loaded onto eIF2. Again, in general, trans-
formed human cell lines displayed significantly higher rates of parts. Translation in mammalian cells is a highly coordinated
process, the regulation of which can be subverted during neo-GDP displacement from eIF2 compared to normal human cells
(Figures 8C and 8D). plastic transformation (Sonenberg, 1993). For example, the
mRNA cap binding factor eIF4E is upregulated in several primaryWe extended these findings by examining whether disregu-
lation of eIF2B activity occurs with any regularity in primary tumors and established cell lines, while the elongation factor
eEF1A has been recently reported to be oncogenic and mutatedhuman tumors. For these studies, we compared a panel of
primary patient-derived Burkitt’s B cell lymphomas to resting in 25% of ovarian tumors (Anand et al., 2002; Zimmer et al.,
2000). Importantly, disruption of the PKR-eIF2 checkpoint hasand lipopolysaccharide (LPS) activated CD19 B cells purified
from human blood. Our initial analysis confirmed that these also been shown to transform NIH3T3 cells, highlighting the
importance of translation initiation control in growth (Sonenberg,lymphomas were significantly more susceptible to VSV than
either resting or activated normal B cells (Supplemental Figure 1993). While several tumorigenic cells appear to have readily
detectable levels of functional PKR, they are capable of sus-S4 at http://www.cancercell.org/cgi/content/full/5/1/51/DC1).
Once more, we found that the Burkitt’s lymphoma samples all taining high levels of protein synthesis (Savinova et al., 1999).
Consequently, these cells support VSV replication despite PKRexhibited significantly greater basal rates of eIF2B-mediated
guanine nucleotide exchange, compared to normal B cells (Fig- activation. Our discovery that rates of eIF2B-catalyzed GDP-
GTP exchange on eIF2 are greatly enhanced in transformedures 8E and 8F). Furthermore, while these GEF rates dropped
in response to tunicamycin-triggered eIF2 kinase activation, MEFs, coupled with the facts that eIF2B	 levels are increased
in these cells, and that this subunit can, by itself, act as athey still remained higher than those found in similarly treated
normal B cells. determinant of permissiveness to VSV, demonstrate that disreg-
ulation of eIF2B can at least partially override the PKR-eIF2Finally, to examine whether disregulated expression of
eIF2B	 occurs in human tumors, we analyzed the transcriptional checkpoint in mammalian cells. In conjunction with previous
results, these data add eIF2B to the growing list of translationexpression of eIF2B	 in a variety of matched normal and tumor
tissue. This preliminary analysis indicated that eIF2B	 mRNA components disregulated during tumorigenesis (Kim et al.,
2000). In this regard, a transformed hamster cell line was recentlywas overexpressed in a significant number of human tumor
samples (Figure 8E). In a few cases, particularly in breast- and reported to display significantly elevated eIF2B activity com-
pared to its normal counterpart, despite comparable eIF2kidney-derived tumors, the expression of eIF2B	 was also ob-
served to decreased, compared to normal tissue, although the phosphorylation (Vojtechova et al., 2003). It is noteworthy that
impaired translation control downstream of eIF2 phosphoryla-reason(s) for this are presently unclear. Nevertheless, these
data, taken in combination with the elevated eIF2B GEF rates tion in cancer cells would not only neutralize the growth-sup-
pressive effects of PKR, but those of PERK and GCN2, as well.seen in many transformed cell lines, indicate that disregulation
of this translational checkpoint may be a common occurrence Since the latter two kinases repress translation following ER
stress and amino acid deprivation, respectively, freedom fromin human cancers.
the consequences of their activation might confer a growth
advantage, favoring rapidly proliferating cells in suboptimal con-Discussion
ditions, particularly if default apoptotic pathways triggered (at
least by PERK inactivation) are also compromised (Harding etThe emergence of VSV as a novel and potent oncolytic agent
has made an investigation into the host cell determinants of al., 2000).
eIF2B is structurally the most complex GEF known, and thepermissiveness to this virus an important objective. In this study,
we made use of a model system of primary and transformed best studied mechanism of regulation of this factor remains
competitive inhibition of its activity by eIF2(ser51P). However,MEFs, as well as of several normal and tumorigenic rodent and
human cell lines, to show that both defective IFN action and in response to insulin and other mitogenic agents, other mecha-
nisms are postulated to regulate eIF2B independent of eIF2impaired translational control can contribute to render cells
highly susceptible to VSV. We found that defects in the control of phosphorylation (Proud, 2001). Recent studies aimed at shed-
ding light on these alternative cascades have identified at leasttranslation were due, at least in part, to disregulation of signaling
downstream of PKR activation and eIF2 phosphorylation, and four different kinases that can phosphorylate eIF2B	 in vitro.
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Figure 6. Sustained overexpression of eIF2B	 in transformed MEFs is required for their increased permissiveness to VSV
A: Transformed MEFs were either treated with the transfection reagent alone (mock), nonspecific siRNA (control), or siRNA to eIF2B	, and eIF2B	 levels were
examined by immunoblotting.
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Figure 7. Recombinant viruses expressing eIF2B	
and eIF2B	
C
A: Schematic of recombinant viruses. The cDNAs
encoding eIF2B	 and eIF2B	
C and GFP were
inserted between the G and L genes of the VSV
genome-encoding plasmid pVSVXN2.
B: BHK cells were infected with recombinant VSV
expressing no transgene (rVSV), GFP (VSV-GFP),
eIF2B	 (VSV-	), or eIF2B	
C (VSV-	
C), and ex-
pression of eIF2B	and eIF2B	
C verified by immu-
noblotting using an antibody specific for rat
eIF2B	 (lanes 1–4). 293T cells were transiently
transfected with either pcDNA3.1Neo() (lane
5), or with pcDNA3.1Neo() encoding eIF2B	 or
eIF2B	
C (lanes 6 and 7, respectively), and ex-
amined for eIF2B	 expression in parallel with the
virally infected cell lysates. These samples were
also examined for VSV proteins by immunoblot-
ting using anti-VSV antiserum (right panel).
C: BHK cells were infected with the indicated
viruses (m.o.i.  0.01), and culture supernatants
examined for viral progeny yield by standard
plaque assay four hours p.i., and every two hours
thereafter for ten hours.
D: These viruses were then used to infect (m.o.i.
0.1 [black bars] or 1 [gray bars]) PKR/ MEFs in
the absence (i) or presence (ii) of anti-mIFN/B
neutralizing antiserum. Culture supernatants
were examined for viral progeny yield 48 hr p.i.
N.D.  none detectable.
Phosphorylation of eIF2B	 by CKI/CKII has been reported to have implicated eIF2B in the eIF2-independent control of pro-
tein synthesis in response to butanol and other fusel alcohols,stimulate eIF2B activity, while phosphorylation by GSK-3 has
an inhibitory effect (Proud, 2001). Importantly, where examined products of amino acid catabolism in yeast (Ashe et al., 2001).
Pathways similar to the ones reported in these studies mayin these studies, virtually no correlation was seen between eIF2
phosphorylation status and stimulation of eIF2B activity by play roles transformed cells, where robust mRNA translation is
sustained despite normal eIF2 phosphorylation.growth factors and mitogens. Similarly, Sachs and colleagues
B: Transformed MEFs treated as above were infected with VSV 72 hr posttransfection. 16 hr p.i., cell viability was analyzed by Trypan blue exclusion.
C: Cells treated with siRNAs and subsequently infected with VSV-GFP as in B were photographed 16 hr p.i. (magnification 200).
D: Viral titers from transformed MEFs treated with the indicated siRNAs and subsequently infected with VSV-GFP (m.o.i.  0.1) was determined 16 hr p.i. by
standard plaque assay. Virus infections were carried out 0 (black bars) or 3 (gray bars) days post siRNA treatment.
E: HeLa cells were treated with the transfection reagent alone (mock), nonspecific siRNA (control), or siRNA to eIF2B	 and eIF2B	 levels examined by
immunoblotting.
F: HeLa cells treated as above were infected with VSV-GFP (m.o.i.  0.1) 72 hr. posttransfection. 24 hr. p.i., cell viability was analyzed by Trypan blue
exclusion.
G: Cells treated with siRNA and subsequently infected with VSV-GFP as in E were photographed 24 hr p.i. (magnification 200).
H: Viral titers were determined 24 hr p.i. by standard plaque assay. Virus infections were carried out 0 (black bars) or 3 (gray bars) days post siRNA treatment.
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Figure 8. Defective translational control and disregulated eIF2B in transformed human cell lines and tumors
A: Four normal (HMVECs, MECs, SAECs, telomerase immortalized fibroblasts) human cell types were treated with either dsRNA (poly [I:C]) or tunicamycin
for three hours, after which they were pulsed with [35S]-labeled methionine and cysteine. Lysates from these cells were analyzed by SDS-PAGE autoradiography
and quantitated by densitometry (top panel).
B: Four transformed (293T, MCF-7, UTA6, and HeLa) human cell types were processed as in A. These lysates were also immunoblotted against antibodies
to eIF2 (total and phosphorylated, bottom panels of A and B).
C: HMVECs, MECs, SAECs, and telomerase-immortalized fibroblasts were treated with or without tunicamycin for three hours and subjected to eIF2B guanine
nucleotide exchange reactions.
D: 293T, MCF-7, UTA6, and HeLa cells were treated with or without tunicamycin and processed as in C. The amount of [3H]GDP bound to eIF2 at the start
of the reaction (time  0 min.) was arbitrarily set to 100%.
E: Resting or LPS (1 g/ml) activated normal CD19 human B cells were treated with or without tunicamycin for three hours, and subjected to eIF2B guanine
nucleotide exchange reactions.
62 CANCER CELL : JANUARY 2004
A R T I C L E
How might increased eIF2B	 levels compromise eIF2 transformed cells, rendering them insensitive to eIF2(ser51P).
Further, since the activity of eIF2B can also be potently affected(ser51P)-dependent control of translation initiation? Since
eIF2B is the rate-limiting component of the guanine nucleotide by phosphorylation and allosteric regulation of eIF2B	, aberran-
cies at this level of regulation may also play roles in disruptingexchange reaction on eIF2, the simplest explanation is that an
increase in the levels of the catalytic subunit is, on its own, the eIF2 checkpoint following cellular transformation, and re-
main to be examined (Proud, 2001). In this regard, it is interestingsufficient to mediate guanine nucleotide exchange on eIF2 inde-
pendent of eIF2 phosphorylation. In vitro, the 	 subunit by to note that forced expression of high levels of eIF2B	, unlike the
case with inactive mutants of eIF2 and PKR, did not transformitself possesses 5%–10% guanine nucleotide exchange activity
of the holocomplex, and overexpression of this polypeptide in NIH3T3 cells, indicating that simply boosting the levels of this
subunit does not disrupt cell growth control in the same manner293 cells causes a marked increase in rates of guanine nucleo-
tide exchange on eIF2 (Fabian et al., 1997; Williams et al., 2001). as certain PKR and eIF2 variants (data not shown, Figure 5E).
The elucidation of the importance of both IFN and translationThese findings support the idea that elevated levels of eIF2B	
levels can, to some extent, override the eIF2(ser51P) transla- control in limiting VSV replication to transformed, but not normal,
cells now allows the development of safer “smart” oncolytictional block. In this regard, the experimental data indicate that
the eIF2B	 of higher eukaryotes may differ from their yeast versions of recombinant VSV expressing, for example, IFN-,
PKR, or eIF2	
C, that will be severely compromised in theirhomologs where simple eIF2B	 is not sufficient to overcome
the potent growth-suppressive effects of eIF2 phosphorylation replication in normal cells, but retain oncolytic activity. For ex-
ample, we have now generated recombinant VSV expressing(Pavitt et al., 1998).
An alternative explanation for how eIF2B	 levels might result IFN-, and report that this virus displays greatly enhanced selec-
tivity for transformed cells in tissue culture and in vivo (Obuchiin an alleviation of the protein synthesis block imposed by
eIF2(ser51P) is provided by the work of Hinnenbusch and col- et al., 2003).
In conclusion, we show that primary MEFs require both PKRleagues who show that, in addition to existing as a pentameric
holocomplex, the five eIF2B subunits can be separated into two and IFN signaling to thwart VSV infection, and neutralization of
both of these pathways, but not either one singly, results indistinct subcomplexes, each of which can independently bind
eIF2 (Pavitt et al., 1998). The subcomplex containing eIF2B , these cells becoming as permissive as transformed MEFs to
VSV. Subsequently, we show that transformed cells possess, and binds more tightly to eIF2(ser51P) than to unphosphor-
ylated eIF2 and exhibits no catalytic activity. In contrast, the defects in IFN antiviral activity, as well as in the PKR pathway
predominantly downstream of eIF2 phosphorylation (Supple-subcomplex comprising eIF2B  and 	manifests higher guanine
nucleotide exchange activity than the wild-type eIF2B holocom- mental Figure S5 at http://www.cancercell.org/cgi/content/full/
5/1/51/DC1). Thus, impairment of these key antiviral pathwaysplex and, surprisingly, is not inhibited by eIF2 phosphorylation
(Pavitt et al., 1998). It is therefore conceivable that an increase may be a common occurrence in tumorigenesis, may predis-
pose transformed cells to infection by VSV, and provide mecha-in the levels of eIF2B	 can titrate eIF2B away from the holocom-
plex and into this eIF2(ser51P)-nonresponsive catalytic sub- nistic insight into the oncolytic properties of this virus.
complex. An increase in the levels of this subcomplex could
Experimental procedurestheoretically mitigate the normally growth-suppressive conse-
quences of eIF2 phosphorylation.
Antibodies and reagents
Although we report an increase in the levels of eIF2B	 as a Polyclonal antiserum to VSV was obtained by immunizing Balb/c mice with
likely reason for the increased permissiveness of transformed wild-type VSV. Other antibodies used were as follows: anti-murine (m) PKR,
MEFs to VSV, and for the hyporesponsiveness to eIF2 phos- anti-eIF2B, anti-eIF2B, anti-eIF2B, anti-eIF2B	 (Santa Cruz Biotech.),
anti-ERK1/2, anti-phospho-ERK1/2, anti-phospho-eIF2 (Biosource Interna-phorylation seen in these cells, it is conceivable that other mech-
tional), anti-p21Ras (Oncogene Research Products), anti-mIFN/ neutraliz-anisms relieving eIF2(ser51P) mediated inhibition of eIF2B may
ing antiserum (Research Disgnostics), anti--actin (Sigma), anti-eIF2B andbe active in neoplastic cells. For example, elegant analyses in
anti-eIF2B	polyclonal antisera (gifts of C. Proud), anti-eIF2 (gift of R. Jagus),
yeast have revealed that mutations in eIF2B which alleviate and anti--tubulin (gift of H. Joshi). Chemicals and other biological reagents
growth suppression induced by eIF2(ser51P) all map to the were obtained from Sigma, except tunicamycin, FTI-277, and PD98059 (Cal-
regulatory , , and  subunits of eIF2B (Pavitt et al., 1997; biochem-Novabiochem Corp.).
Vazquez de Aldana and Hinnebusch, 1994). In fact, complete
Cell linesdeletion in vivo of the yeast eIF2B homolog, or exclusion of
PKR/ and PKR/ (129 terSv  Balb/c) MEFs, STAT1/ and STAT1/this subunit from in vitro eIF2 GEF assays, completely alleviates
immortalized cell lines and MEFs (gift of J.Durbin), as well as their trans-suppression of eIF2B by eIF2 phosphorylation without affect-
formed counterparts, Balb-3T3 and Balb-Ras (gift of D. Faller), 293T (gift of
ing eIF2B GEF activity (Dever et al., 1993; Kimball et al., 1998). P. Vertino), HeLa, BHK, C6 rat glioblastoma, MCF-7, and Cos-7 cells (ATCC)
It is therefore possible that mutations and/or deletions analo- were maintained in DMEM supplemented with 10% FBS and antibiotics.
NIH3T3 cells were maintained in DMEM supplemented with 10% FCS andgous to those reported in these studies might also occur in
F: Four patient-derived Burkitt’s lymphomas (SM-1, BL-3, BL-5, and BL-8) were treated with or without tunicamycin for three hours, and subjected to eIF2B
guanine nucleotide exchange reactions.
G: The Cancer Profiling Array II blot (Clontech) containing pairs of normal (N) and tumor (T) tissue samples (each pair from an individual patient) spotted
side by side was probed with a radiolabeled 1.6 kb XhoI-HindIII derived fragment of the human eIF2B	 gene (Genbank accession number XM_029136)
and exposed to X-ray film. The tissue of origin is indicated above each strip. Asterisks indicate sample pairs in which the eIF2B	 mRNA is upregulated, while
solid triangles indicate sample pairs where eIF2B	 mRNA expression is reduced in tumor tissue, compared to the normal tissue.
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antibiotics. Primary human cells (HMVECs, MECs, SAECs) were propagated We thank J. Durbin, D. Faller, W. Hahn, S. Kimball, D. Levy, C. Proud, W.
in media as recommended (Clonetics/BioWhittaker, Inc.). Telomerase- Harrington, and P. Vertino for cell lines, plasmids, and reagents. Gratitude
immortalized human fibroblasts (Clontech, gift of W. Hahn), were grown in is extended to H. Ezelle, R. Jagus, and S. Kimball for critically reviewing the
DMEM supplemented with 25% Medium 199, 10% FBS, and antibiotics. manuscript and for experimental assistance.
CD19 B cells were purified from human buffy coat using a positive selection
technique, as per the manufacturer’s instructions (Miltenyi Biotec Inc.), and
cultured in RPMI supplemented with 10% FBS and antibiotics, with or with
1 g/ml E. coli LPS for 24 hr before experiments. The Burkitt’s lymphoma Received: May 30, 2003
patient isolates (SM-1, BL-3, BL-5, and BL-8) were obtained following ap- Revised: October 8, 2003
proval by the University of Miami Institutional Review Board/Medical Sci- Accepted: October 29, 2003
ences Committee (courtesy of Dr. W. Harrington, Jr.; Lee et al., 1999). Published: January 19, 2004
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